Indicators for early assessment of palliative care in lung cancer patients: a population study using linked health data

BMC Palliative Care
Maria KellyAilish Hannigan

Abstract

Analysing linked, routinely collected data may be useful to identify characteristics of patients with suspected lung cancer who could benefit from early assessment for palliative care. The aim of this study was to compare characteristics of newly diagnosed lung cancer patients dying within 30 days of diagnosis (short term survivors) with those surviving more than 30 days. To identify indicators for early palliative care assessment we distinguished between characteristics available at diagnosis (age, gender, smoking status, marital status, comorbid disease, admission type, tumour stage and histology) from those available post diagnosis. A second aim was to examine the association between receiving any tumour-directed treatment, place of death and survival time. A retrospective observational population based study comparing lung cancer patients who died within 30 days of diagnosis (short term survivors) with those who survived longer using Chi-squared tests and logistic regression. Incident lung cancer (ICD-03:C34) patients diagnosed 2005-2012 inclusive who died before 01-01-2014 (n = 14,228) were identified from the National Cancer Registry of Ireland linked to death certificate data and acute hospital episode data. One in five ...Continue Reading

References

May 15, 1997·Statistics in Medicine·D W HosmerS Lemeshow
Feb 7, 1998·Medical Care·A ElixhauserR M Coffey
May 2, 2008·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jean-Paul SculierUNKNOWN International Staging Committee and Participating Institutions
Sep 8, 2010·The New England Journal of Medicine·Jennifer S TemelThomas J Lynch
May 11, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer S TemelWilliam F Pirl
Feb 22, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B GomesUNKNOWN PRISMA
Feb 19, 2013·BMC Palliative Care·Barbara GomesIrene J Higginson
Aug 21, 2013·Irish Journal of Medical Science·K O'BrienL Sharp
Sep 21, 2013·British Journal of Cancer·S McPhailM Richards
May 2, 2014·BMJ Supportive & Palliative Care·Catriona KennedySusie Chater
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Dec 11, 2014·BMJ Supportive & Palliative Care·Mary Jane O'LearyTony O'Brien
Jun 10, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter MayR Sean Morrison
Oct 1, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Silvia FrancisciUNKNOWN EUROCARE-5 Working Group:
Jan 20, 2016·JAMA : the Journal of the American Medical Association·Justin E BekelmanUNKNOWN International Consortium for End-of-Life Research (ICELR)
Mar 2, 2016·BMJ Supportive & Palliative Care·Joanna M DaviesJulia Verne
Jun 19, 2016·Palliative Medicine·Peter TanuseputroWalter P Wodchis
Apr 26, 2017·Palliative Medicine·Peter Tanuseputro
Aug 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B GomesUNKNOWN PRISMA

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.